Investment Firm Concentric Wealth Management's Q3 vs. Q4 2022 13F Holdings Analysis

Concentric Wealth Management is an investment firm that manages over $100 million in assets. The firm recently filed its Q3 and Q4 2022 13F holdings reports, providing investors with an update on the changes in the firm's holdings over the last few months.

In the Q3 2022 vs. Q4 2022 analysis, there were some interesting changes to Concentric Wealth Management's portfolio. The top holding for the firm remained the iShares Russell 2000 Value ETF (IWN). However, the firm increased its shares in IWN from 91,583 to 92,029, a change of 8.1%. The value of the shares also increased from $11,808,000 to $12,761,000, a substantial increase of 8.1%.

Another interesting change to Concentric Wealth Management's portfolio was the decrease in shares of the iShares Short-Term Corporate Bond ETF (IGSB). The firm reduced its shares of IGSB from 139,054 to 129,029, which is a change of -6.2%. The value of the shares also decreased from $6,853,000 to $6,428,000, a change of -6.2%.

One sector that Concentric Wealth Management has shown a strong interest in is healthcare. The firm increased its shares in Johnson & Johnson (JNJ) from 46,379 to 45,202, a change of -5.4%. However, the value of the shares increased from $7,576,000 to $7,984,000, a change of 5.4%. Abbvie Inc. (ABBV) was another healthcare holding that saw a decrease in shares from 45,968 to 41,513, a change of -8.8%. The value of the shares decreased from $6,169,000 to $6,708,000, a change of -8.8%.

Technology was another sector that saw some changes to Concentric Wealth Management's portfolio. The firm increased its shares in Microsoft (MSFT) from 33,514 to 33,726, a change of 3.6%. The value of the shares increased from $7,805,000 to $8,088,000, a change of 3.6%. However, the firm decreased its shares of Alphabet (Google) A (GOOGL) from 71,290 to 72,267, a change of -6.5%. The value of the shares also decreased from $6,819,000 to $6,376,000, a change of -6.5%.

In terms of new holdings, Concentric Wealth Management added shares in Denali Therapeutics (DNLI) and Matson, Inc. (MATX). The firm invested 27,967 shares in DNLI, valued at $777,000. Concentric Wealth Management also invested 11,584 shares in MATX, valued at $724,000.

In summary, Concentric Wealth Management's Q3 vs Q4 2022 13F holdings analysis shows that the firm made some interesting changes to its portfolio. The firm increased its holdings in the iShares Russell 2000 Value ETF (IWN), Microsoft (MSFT), and Johnson & Johnson (JNJ), while decreasing its holdings in the iShares Short-Term Corporate Bond ETF (IGSB), Abbvie Inc. (ABBV), and Alphabet (Google) A (GOOGL). Additionally, the firm added two new holdings in Denali Therapeutics (DNLI) and Matson, Inc. (MATX). Investors can use this information to make informed decisions when it comes to managing their own portfolios.